276 related articles for article (PubMed ID: 25002206)
1. Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
Qiu GH; Xie X; Xu F; Shi X; Wang Y; Deng L
Cytotechnology; 2015 Jan; 67(1):1-12. PubMed ID: 25002206
[TBL] [Abstract][Full Text] [Related]
2. Comparative Transcriptomic Analysis of Three Common Liver Cell Lines.
Arzumanian V; Pyatnitskiy M; Poverennaya E
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240140
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell lines.
Papachristou F; Anninou N; Koukoulis G; Paraskakis S; Sertaridou E; Tsalikidis C; Pitiakoudis M; Simopoulos C; Tsaroucha A
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jun; 866():503352. PubMed ID: 33985696
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
6. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
7. [Adenovirus vector expressing MDA-7/IL-24 selectively induces growth arrests and apoptosis in human hepatocellular carcinoma cell lines independent of the state of p53 gene].
Xue XB; Zheng JW; Wang CJ; Chen K; Hu HY; Hu H; Yu Y; Wu ZD
Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):670-5. PubMed ID: 16995981
[TBL] [Abstract][Full Text] [Related]
8. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines.
Lee TK; Lau TC; Ng IO
Cancer Chemother Pharmacol; 2002 Jan; 49(1):78-86. PubMed ID: 11855756
[TBL] [Abstract][Full Text] [Related]
11. Increase in the nuclear localization of PTEN by the Toxoplasma GRA16 protein and subsequent induction of p53-dependent apoptosis and anticancer effect.
Kim SG; Seo SH; Shin JH; Yang JP; Lee SH; Shin EH
J Cell Mol Med; 2019 May; 23(5):3234-3245. PubMed ID: 30834688
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation, invasion and adhesion of liver cancer cells by 5-azacytidine and butyrate.
Wang XM; Li J; Evers BM
Anticancer Res; 1999; 19(4B):2901-6. PubMed ID: 10652571
[TBL] [Abstract][Full Text] [Related]
13. Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways.
Wenger RH; Marti HH; Bauer C; Gassmann M
Int J Mol Med; 1998 Sep; 2(3):317-24. PubMed ID: 9855704
[TBL] [Abstract][Full Text] [Related]
14. In silico analysis of the binding properties of solasonine to mortalin and p53, and in vitro pharmacological studies of its apoptotic and cytotoxic effects on human HepG2 and Hep3b hepatocellular carcinoma cells.
Pham MQ; Tran THV; Pham QL; Gairin JE
Fundam Clin Pharmacol; 2019 Aug; 33(4):385-396. PubMed ID: 30628118
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and melatonin protect the cell's viability and ameliorate the CCl4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell lines.
Özerkan D; Özsoy N; Yılmaz E
Cytotechnology; 2015 Dec; 67(6):995-1002. PubMed ID: 24997582
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B.
Thongtan T; Panyim S; Smith DR
J Med Virol; 2004 Mar; 72(3):436-44. PubMed ID: 14748067
[TBL] [Abstract][Full Text] [Related]
17. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
Emani S; Zhang J; Guo L; Guo H; Kuo PC
Surgery; 2008 Jun; 143(6):803-12. PubMed ID: 18549897
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2.
Forte TM; McCall MR; Knowles BB; Shore VG
J Lipid Res; 1989 Jun; 30(6):817-29. PubMed ID: 2551986
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced intercellular signaling mediated by cytochrome-c via a p53-dependent pathway in hepatoma cells.
He M; Zhao M; Shen B; Prise KM; Shao C
Oncogene; 2011 Apr; 30(16):1947-55. PubMed ID: 21132005
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells.
Qin LF; Ng IO
Cancer Lett; 2002 Jan; 175(1):27-38. PubMed ID: 11734333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
